Cargando…

NLRP3: a new therapeutic target in alcoholic liver disease

The liver is in charge of a wide range of critical physiological processes and it plays an important role in activating the innate immune system which elicits the inflammatory events. Chronic ethanol exposure disrupts hepatic inflammatory mechanism and leads to the release of proinflammatory mediato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brahadeeswaran, Subhashini, Dasgupta, Tiasha, Manickam, Venkatraman, Saraswathi, Viswanathan, Tamizhselvi, Ramasamy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374212/ https://www.ncbi.nlm.nih.gov/pubmed/37520548 http://dx.doi.org/10.3389/fimmu.2023.1215333

Ejemplares similares

Assessment of Anticarcinogenic Potential of Vitex trifolia and Triticum aestivum Linn by In Vitro Rat Liver Microsomal Degranulation
por: Mathankumar, Marimuthu, et al.
Publicado: (2015)

Assessment of the Role of Noni (Morinda citrifolia) Juice for Inducing Osteoblast Differentiation in Isolated Rat Bone Marrow Derived Mesenchymal Stem Cells
por: Hussain, Sharmila, et al.
Publicado: (2016)

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer
por: Tezcan, Gulcin, et al.
Publicado: (2021)

The NLRP3 inflammasome as a new target in respiratory disorders treatment
por: Leszczyńska, Katarzyna, et al.
Publicado: (2022)

The Potential Therapeutic Role of miR-223 in Bovine Endometritis by Targeting the NLRP3 Inflammasome
por: Zhao, Gan, et al.
Publicado: (2018)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
por: Moltrasio, Chiara, et al.
Publicado: (2022)

The immune response as a therapeutic target in non-alcoholic fatty liver disease
por: Ortiz-López, Nicolás, et al.
Publicado: (2022)

Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
por: Wu, Xiaoqin, et al.
Publicado: (2017)

Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019)

Targeting the NLRP3 Inflammasome in Severe COVID-19
por: Freeman, Tracey L., et al.
Publicado: (2020)

Mechanistic and therapeutic insights into the function of NLRP3 inflammasome in sterile arthritis
por: Xiao, Yi, et al.
Publicado: (2023)

Reframing the link between metabolism and NLRP3 inflammasome: therapeutic opportunities
por: Ortega, Miguel A., et al.
Publicado: (2023)

Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets
por: Paquissi, Feliciano Chanana
Publicado: (2016)

Editorial: NLRP3 Inflammasome: Regulatory Mechanisms, Role in Health and Disease and Therapeutic Potential
por: Chernikov, Oleg V., et al.
Publicado: (2021)

The Role of NLRP3 Inflammasome Activation Pathway of Hepatic Macrophages in Liver Ischemia–Reperfusion Injury
por: Wu, Tong, et al.
Publicado: (2022)

Targeting NLRP3 Inflammasome With Nrf2 Inducers in Central Nervous System Disorders
por: Tastan, Bora, et al.
Publicado: (2022)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Succinate/NLRP3 Inflammasome Induces Synovial Fibroblast Activation: Therapeutical Effects of Clematichinenoside AR on Arthritis
por: Li, Yi, et al.
Publicado: (2016)

Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS
por: Clénet, Marie-Laure, et al.
Publicado: (2023)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles
por: Aghara, Hiral, et al.
Publicado: (2023)

DDX3X Links NLRP11 to the Regulation of Type I Interferon Responses and NLRP3 Inflammasome Activation
por: Kienes, Ioannis, et al.
Publicado: (2021)

Alum Activates the Bovine NLRP3 Inflammasome
por: Harte, Ciaran, et al.
Publicado: (2017)

NLRP3 Inflammasome and Inflammatory Bowel Disease
por: Zhen, Yu, et al.
Publicado: (2019)

Interplay Between NLRP3 Inflammasome and Autophagy
por: Biasizzo, Monika, et al.
Publicado: (2020)

The Role of NLRP3 Inflammasome in Pneumococcal Infections
por: Surabhi, Surabhi, et al.
Publicado: (2020)

NLRP3: Role in ischemia/reperfusion injuries
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

NLRP3 inflammasome activation in response to metals
por: Huang, Wanyi, et al.
Publicado: (2023)

Editorial: Novel perspectives on the NLRP3 inflammasome
por: Liang, Ying, et al.
Publicado: (2023)

Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization
por: Malsy, Jakob, et al.
Publicado: (2020)

Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3
por: Ma, Xingyu, et al.
Publicado: (2022)

Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease
por: Bartneck, Matthias, et al.
Publicado: (2019)

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019)

Macrophage Sphingosine 1-Phosphate Receptor 2 Blockade Attenuates Liver Inflammation and Fibrogenesis Triggered by NLRP3 Inflammasome
por: Hou, Lei, et al.
Publicado: (2020)

Double-Negative T Cells Regulate Hepatic Stellate Cell Activation to Promote Liver Fibrosis Progression via NLRP3
por: Yang, Yi, et al.
Publicado: (2022)

Exercise training-attenuated insulin resistance and liver injury in elderly pre-diabetic patients correlates with NLRP3 inflammasome
por: Zhang, Tan, et al.
Publicado: (2023)

The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?
por: Le Daré, Brendan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o6i43sck4td449faepp6pj36g7